republic-os/legal/us/code/title-22/chapter-32/section-2291l.md

type, title, description, jurisdiction, corpus, kind, title_number, title_name, chapter_number, chapter_name, section, citation, status, release_point, release_date, source, source_url, source_identifier, source_file, source_hash, raw_snapshot_hash, text_hash, retrieved_at, confidence, tags

type	title	description	jurisdiction	corpus	kind	title_number	title_name	chapter_number	chapter_name	section	citation	status	release_point	release_date	source	source_url	source_identifier	source_file	source_hash	raw_snapshot_hash	text_hash	retrieved_at	confidence	tags
LegalText	22 U.S.C. § 2291l	Prioritization of efforts of the Department of State to combat international trafficking in covered synthetic drugs	us	united_states_code	code_section	22	FOREIGN RELATIONS AND INTERCOURSE	32	FOREIGN ASSISTANCE	2291l	22 U.S.C. § 2291l	current	119-100	2026-06-26	official	https://uscode.house.gov/download/releasepoints/us/pl/119/100/xml_usc22@119-100.zip	/us/usc/t22/s2291l	data/legal/raw/us/code/title-22/usc22.xml	255669679610bfb530a2b09f4e01caa725b81a987e92d320847e7b2a6af4317f	b9c63ede722f5e0bf8eabfe9029e06e312ab9bcfd95c4d1424ed515baff1df83	ef10662d2c6236b1c7fba803f166fe7609d6c57e86134f5b661661b0ab38e567	2026-07-04	official	legal us-code

22 U.S.C. § 2291l - Prioritization of efforts of the Department of State to combat international trafficking in covered synthetic drugs

Text

(a) In general The Secretary of State shall prioritize efforts of the Department of State to combat international trafficking of covered synthetic drugs by carrying out programs and activities to include the following:

(1) Supporting increased data collection by the United States and foreign countries through increased drug use surveys among populations, increased use of wastewater testing where appropriate, and multilateral sharing of that data.

(2) Engaging in increased consultation and partnership with international drug agencies, including the European Monitoring Centre for Drugs and Drug Addiction, regulatory agencies in foreign countries, and the United Nations Office on Drugs and Crime.

(3) Carrying out programs to provide technical assistance and equipment, as appropriate, to strengthen the capacity of foreign law enforcement agencies with respect to covered synthetic drugs, as required by section 2291m of this title.

(4) Carrying out exchange programs for governmental and nongovernmental personnel in the United States and in foreign countries to provide educational and professional development on demand reduction matters relating to the illicit use of covered synthetic drugs and other drugs, as required by section 2291n of this title.

(b) Report (1) In general Not later than one year after December 23, 2022, the Secretary of State shall submit to the appropriate congressional committees a report on the implementation of this section.

(2) Appropriate congressional committees defined In this subsection, the term “appropriate congressional committees” means—

(A) the Committee on Foreign Relations, the Committee on Appropriations, and the Committee on the Judiciary of the Senate; and

(B) the Committee on Foreign Affairs, the Committee on Appropriations, and the Committee on the Judiciary of the House of Representatives.

(Pub. L. 117–263, div. E, title LV, § 5552, Dec. 23, 2022, 136 Stat. 3341.)

Notes

Editorial Notes

Codification Section was enacted as part of the Fighting Emerging Narcotics Through Additional Nations to Yield Lasting Results Act, also known as the FENTANYL Results Act, and also as part of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, and not as part of the Foreign Assistance Act of 1961 which comprises this chapter.

Statutory Notes and Related Subsidiaries

Rule of ConstructionPub. L. 117–263, div. E, title LV, § 5557, Dec. 23, 2022, 136 Stat. 3344, provided that: “Nothing in this subtitle [subtitle C (§§ 5551–5558) of title LV of div. E of Pub. L. 117–263, see Short Title of 2022 Amendment note set out under section 2151 of this title] or the amendments made by this subtitle shall be construed to affect the prioritization of extradition requests.”

Definitions Pub. L. 117–263, div. E, title LV, § 5558, Dec. 23, 2022, 136 Stat. 3344, provided that: “In this subtitle [subtitle C (§§ 5551–5558) of title LV of div. E of Pub. L. 117–263, see Short Title of 2022 Amendment note set out under section 2151 of this title]: “(1) Controlled substance; controlled substance analogue.—The terms ‘controlled substance’ and ‘controlled substance analogue’ have the meanings given those terms in section 102 of the Controlled Substances Act (21 U.S.C. 802). “(2) Covered synthetic drug.—The term ‘covered synthetic drug’ means—“(A) a synthetic controlled substance or synthetic controlled substance analogue, including fentanyl or a fentanyl analogue; or “(B) a new psychoactive substance. “(3) New psychoactive substance.—The term ‘new psychoactive substance’ means a substance of abuse, or any preparation thereof, that—“(A) is not—“(i) included in any schedule as a controlled substance under the Controlled Substances Act (21 U.S.C. 801 et seq.); or “(ii) controlled by the Single Convention on Narcotic Drugs, done at New York March 30, 1961, or the Convention on Psychotropic Substances, done at Vienna February 21, 1971; “(B) is new or has reemerged on the illicit market; and “(C) poses a threat to the public health and safety.”